| Literature DB >> 33659125 |
Amal Haoudar1, Nabila Chekhlabi2, Madiha Eljazouly3, Chafik El Kettani1, Nezha Dini4.
Abstract
Until October 2020, children seem to have a mild form of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Morocco. Since April 2020, a new entity of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection was reported in England, Italy, France, and the United States. This syndrome has similarities with the most frequent vasculitis in children, Kawasaki disease. Here, we describe the features and outcome of the first five cases of Kawasaki-like multisystem inflammatory syndrome in Moroccan children triggered by the SARS-CoV-2. The median age of the children was 7.8 years; three of them were boys. Criteria for Kawasaki disease were met in all of them with a complete presentation. Three patients required admission to a critical care unit with multi-organ failure in one of them, but no mortality occurred. They all received intravenous immunoglobulin (IVIG), a high dose of aspirin, methylprednisolone, and supportive therapy. Coronavirus 2019 disease (COVID-19) infection in children may be life-threatening; rigorous monitoring for several weeks is required in any positive child or living in a family cluster.Entities:
Keywords: coronary artery dilation; kawasaki disease; multisystem inflammatory syndrome; sars-cov-2
Year: 2021 PMID: 33659125 PMCID: PMC7916987 DOI: 10.7759/cureus.12991
Source DB: PubMed Journal: Cureus ISSN: 2168-8184